iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.85+0.10 (+13.37%)
Close on Nov 18, 2026Market cap $54.54MP/E –Yield –
iBio revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
iBio's revenue for the twelve months ending Sep 30, 2026 was $1.08M, up 115.0% year over year. For fiscal 2026 it was $100.00K, down 75.0% from the year before. Over ten years it grew -20.1% a year on average. The highest annual figure on record is $2.37M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $100.00K | -75.0% |
| FY2025 | Jun 30, 2025 | $400.00K | +77.8% |
| FY2024 | Jun 30, 2024 | $225.00K | – |
| FY2023 | Jun 30, 2023 | $0 | -100.0% |
| FY2022 | Jun 30, 2022 | $1.88M | -20.5% |
| FY2021 | Jun 30, 2021 | $2.37M | +44.7% |
| FY2020 | Jun 30, 2020 | $1.64M | -18.8% |
| FY2019 | Jun 30, 2019 | $2.02M | +354.5% |
| FY2018 | Jun 30, 2018 | $444.00K | +12.7% |
| FY2017 | Jun 30, 2017 | $394.00K | -58.4% |
| FY2016 | Jun 30, 2016 | $948.00K | -48.8% |
| FY2015 | Jun 30, 2015 | $1.85M | +802.9% |
| FY2014 | Jun 30, 2014 | $205.00K | -79.6% |
| FY2013 | Jun 30, 2013 | $1.01M | -21.1% |
| FY2012 | Jun 30, 2012 | $1.28M | +145.5% |
| FY2011 | Jun 30, 2011 | $520.08K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $1.08M | +975.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $0 | -100.0% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0 | -100.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $100.00K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $200.00K | +14.3% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $200.00K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $0 | -100.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $175.00K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $0 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $50.00K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $0 | -100.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $0 | -100.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0 | -100.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.80M | +339.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $491.00K | -56.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $765.00K | +696.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $705.00K | +124.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $410.00K | +279.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $1.12M | +40.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $96.00K | -81.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $314.00K | -51.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $108.00K | +140.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $795.00K | +773.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $527.00K | +575.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $651.00K | +325.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $45.00K | -63.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $91.00K | -38.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $78.00K | +110.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $153.00K | +104.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $122.00K | -9.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $147.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $37.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $75.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $135.00K | – |
See a number that looks wrong?